Clinicopathological features of inflammatory myofibroblastic tumor
10.3760/cma.j.cn112151-20200806-00627
- VernacularTitle:炎性肌纤维母细胞肿瘤临床病理学分析
- Author:
Yan ZHU
1
;
Ying DING
;
Guoxin SONG
;
Xiao LI
;
Ru DING
;
Qinhe FAN
;
Qixing GONG
Author Information
1. 江苏省人民医院（南京医科大学第一附属医院）病理学部 210029
- Keywords:
Soft tissue neoplasms;
Myofibroblasts;
In situ hybridization, fluorescence
- From:
Chinese Journal of Pathology
2021;50(3):194-200
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinicopathological diagnosis and differential diagnosis of inflammatory myofibroblastic tumor (IMT).Methods:Thirty-two cases of IMT collected at the People′s Hospital of Jiangsu Province from May 2010 to May 2020 were evaluated for their clinical, histologic, immunohistochemical and genomic features, and relevant literature was reviewed.Results:There were 19 male and 13 female patients, with age ranging from 5 to 65 years (mean, 37 years). The tumors were located in the lung and mediastinum (10 cases), gastrointestinal tract and mesentery/omentum (12 cases), urinary bladder (5 cases), head and neck (3 cases), somatic soft tissue (1 case), and retroperitoneum (1 case). Four cases of epithelioid inflammatory myofibroblastic sarcoma (EIMS) were all located intra-abdominally. Histologically, the tumor cells were myofibroblasts and fibroblasts arranged in predominantly fusiform pattern, with variably edematous to myxoid background or sclerotic collagenized stroma, and variably mixed chronic or acute inflammatory cells infiltration. EIMS were composed mainly of epithelioid tumor cells, with myxoid stroma and numerous neutrophils. Immunohistochemically, the tumor cells expressed cytoplasmic ALK (25/32, 78%), whereas the four EIMS showed nuclear membrane ALK staining pattern. The tumor cells also expressed CKpan (8/19), SMA (24/32, 75%) and desmin (12/32, 38%); all four EIMS also showed strong positivity for desmin. Fluorescence in situ hybridization (FISH) for ALK gene rearrangement showed split apart signals in 12 of 15 cases, most commonly with atypical signals. Next-generation sequencing (NGS) was performed in three tumors and showed that one case of lower leg IMT harbored a novel CLIP2-ALK fusion, and two cases of EIMS harbored RANBP2-ALK fusion. Follow-up data were available in 29 patients. Twenty-two patients were alive with no evidence of tumor, four patients had tumor recurrences (three patients were treated with crizotinib and were alive with tumor), and three patients died of the disease (including two patients with EIMS).Conclusions:IMTs show a wide morphologic spectrum, and should be differentiated form a variety of benign or malignant tumors. Immunohistochemistry (ALKp80, ALKD5F3) and FISH (ALK break-apart probe) could assist the diagnosis of IMT, with NGS recommended for the atypical cases.
